NCT01953757

Brief Summary

The purpose of this study is to assess whether, in individuals with diabetic neuropathy, a low-fat, vegan diet in combination with a vitamin B12 supplement improves pain, sensation and other subjective symptoms, more effectively than a vitamin B12 supplement with no diet changes. The principal measure is pain as measured by the following assessment tools: Michigan Neuropathy Screening Instrument, Norfolk Quality of Life Questionnaire, Neuropathy Impairment Score - Lower Limbs, Neuropathy Total Symptom Score, Neuropathy Pain Scale, McGill Pain Questionnaire and Global Impression Scale. The study duration is 20 weeks. This study also examines the effects of a low-fat, vegan diet on mood, using the Center for Epidemiologic Studies Depression Scale-Revised, and the Beck Depression Inventory.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 1, 2013

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

April 27, 2015

Status Verified

April 1, 2015

Enrollment Period

1.5 years

First QC Date

September 26, 2013

Last Update Submit

April 24, 2015

Conditions

Keywords

diabetic neuropathy, diet, vegan, vegetarian

Outcome Measures

Primary Outcomes (1)

  • Pain

    Pain will be measured follow the baseline and 20 week score using the following assessment tools: Michigan Neuropathy Screening Instrument Norfolk Quality of Life Questionnaire Neuropathy Impairment Score - Lower Limbs Neuropathy Total Symptom Score 6 Neuropathy Pain Scale McGill Pain Questionnaire Global Impression Scale

    20 weeks

Secondary Outcomes (5)

  • Sensation

    20 Weeks

  • Disease activity

    20 Weeks

  • Glycemic control

    20 Weeks

  • Mood

    20 Weeks

  • Quality of life

    20 Weeks

Other Outcomes (1)

  • Acceptability of vegan diet

    20 Weeks

Study Arms (2)

Vegan diet and vitamin B12 supplement

EXPERIMENTAL

The diet/supplement group will be asked to follow a low-fat, vegan diet for 20 weeks, and take a vitamin B12 supplement daily.

Other: Vegan diet and vitamin B12 supplement

Vitamin B12 supplement

ACTIVE COMPARATOR

The supplement group will be asked to take a daily vitamin B12 supplement, and to make no changes to their current diet.

Dietary Supplement: Vitamin B12 supplement

Interventions

A low-fat, vegan diet (no meat, fish, eggs or dairy products) and a vitamin B12 supplement in the form of 2000mcg of methylcobalamin

Also known as: Vegan diet
Vegan diet and vitamin B12 supplement
Vitamin B12 supplementDIETARY_SUPPLEMENT

A daily vitamin B12 supplement in the form of 2000mcg of methylcobalamin

Also known as: B12
Vitamin B12 supplement

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women age 18 - 65 years old
  • A diagnosis of type 2 diabetes
  • A diagnosis of diabetic neuropathy for at least 6 months or symptoms of diabetic neuropathy for at least 6 months
  • Score of greater than 2 on the Michigan Neuropathy Screening Instrument
  • Score of greater than 6on the Norfolk Quality of Life Questionnaire
  • Score of greater than 2 on the Neuropathy Impairment Score for Lower Limbs (NIS-LL)
  • Score of greater than 1 on the Neuropathy Total Symptom Score 6 (NTSS-6)

You may not qualify if:

  • Vitamin B12 deficiency
  • Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
  • Pregnancy
  • Unstable medical or psychiatric illness
  • Likely to be disruptive in group sessions (as determined by research staff)
  • Already following a low-fat, vegan diet
  • Lack of English fluency
  • Inability to maintain current medication regimen
  • Inability or unwillingness to participate in all components of the study
  • Sensitivity to lidocaine or epinephrine (or their preservatives)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physicians Committee for Responsible Medicine

Washington D.C., District of Columbia, 20016, United States

Location

MeSH Terms

Conditions

Diabetic Neuropathies

Interventions

Diet, VeganVitamin B 12

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Diet, VegetarianDiet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaCorrinoidsTetrapyrrolesPyrrolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingMacrocyclic CompoundsPolycyclic Compounds

Study Officials

  • Neal Barnard, MD

    Physicians Committee for Responsible Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2013

First Posted

October 1, 2013

Study Start

September 1, 2013

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

April 27, 2015

Record last verified: 2015-04

Locations